Magnetic catechin-dextran conjugate as targeted therapeutic for pancreatic tumour cells

Journal of Drug Targeting

Volumn 22, Issue 5, 2014, Pages 408-415

  Vittorio, Orazio ^a   Voliani, Valerio ^b,c   Faraci, Paolo ^b   Karmakar, Biswajit ^b,d   Iemma, Francesca ^e   Hampel, Silke ^f   Kavallaris, Maria ^a   Cirillo, Giuseppe ^e,f  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ISTITUTO NANOSCIENZE CNR   (Italy)

^c CENTER FOR NANOTECHNOLOGY INNOVATION NEST   (Italy)

^d SAHA INSTITUTE OF NUCLEAR PHYSICS   (India)

^e UNIVERSITY OF CALABRIA   (Italy)

^f IFW DRESDEN   (Germany)

Author keywords

Anticancer activity; Catechin; Dextran; Magnetic nanoparticles; Polymer therapeutics

Indexed keywords

ANTINEOPLASTIC AGENT; CATECHIN; DEXTRAN DERIVATIVE; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE CATECHIN DEXTRAN CONJUGATE; UNCLASSIFIED DRUG; DEXTRAN; MAGNETITE NANOPARTICLE; NANOCONJUGATE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG TUMOR LEVEL; HUMAN; HUMAN CELL; MAGNETIC FIELD; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; CELL SURVIVAL; CHEMISTRY; CULTURE TECHNIQUE; DRUG EFFECTS; LIGHT; RADIATION SCATTERING; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CATECHIN; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; DEXTRANS; HUMANS; LIGHT; MAGNETITE NANOPARTICLES; NANOCONJUGATES; SCATTERING, RADIATION;

EID: 84901030180     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2013.878941     Document Type: Article

References (48)

1. Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 2006;545:51-64
2. Yang CS, Chung JY, Yang G, et al. Tea and tea polyphenols in cancer prevention. J Nutr 2000;130:472S-8S
3. Cooper R, Morre DJ, Morre DM. Medicinal benefits of green tea. Part II. Review of anticancer properties. J Altern Complement Med 2005;11:639-52
4. Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 2009;9:429-39
5. Yang CS, Wang X. Green tea and cancer prevention. Nutr Cancer 2010;62:931-7
6. Han H, Shen T, Lou H. Dietary polyphenols and their biological significance. Int J Mol Sci 2007;8:950-88
7. Leone M, Zhai D, Sareth S, et al. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl- 2-family proteins. Cancer Res 2003;63:8118-21
8. Pellecchia M, Reed JC. Inhibition of anti-apoptotic Bcl-2 family proteins by natural polyphenols: new avenues for cancer chemoprevention and chemotherapy. Curr Pharm Des 2004;10: 1387-98
9. Jung YD, Kim MS, Shin BA, et al. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer 2001;84:844-50
10. Chow HH, Hakima IA. Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacol Res 2011;64:105-12
11. Fraga CG, Oteiza PI. Dietary flavonoids: role of (-)-epicatechin and related procyanidins in cell signaling. Free Rad Biol Med 2011; 51:813-23
12. Yuan J-M, Sun C, Butler LM. Tea and cancer prevention: epidemiological studies. Pharmacol Res 2011;64:123-35
13. Saikia JP, Konwarh R, Konwar BK, Karak N. Isolation and immobilization of Aroid polyphenol on magnetic nanoparticles: enhancement of potency on surface immobilization. Coll Surf B Bioint 2012;102:450-6
14. Zolotarskaya OY, Wagner AF, Beckta JM, et al. Synthesis of watersoluble camptothecin-polyoxetane conjugates via click chemistry. Mol Pharm 2012;9:3403-8
15. Cirillo G, Vittorio O, Hampel S, et al. Incorporation of carbon nanotubes into a gelatin-catechin conjugate: innovative approach for the preparation of anticancer materials. Int J Pharm 2013;446: 176-82
16. Cirillo G, Vittorio O, Hampel S, et al. Quercetin nanocomposite as novel anticancer therapeutic: improved efficiency and reduced toxicity. Eur J Pham Sci 2013;49:359-65
17. Vittorio O, Cirillo G, Iemma F, et al. Dextran-catechin conjugate: a potential treatment against the pancreatic ductal adenocarcinoma. Pharm Res 2012;29:2601-14
18. Miyano T, Wijagkanalan W, Kawakami S, et al. Anionic amino acid dendrimer-trastuzumab conjugates for specific internalization in HER2-positive cancer cells. Mol Pharm 2010;7: 1318-27
19. Duncan R, Gaspar R. Nanomedicine(s) under the microscope. Mol Pharm 2012;8:2101-41
20. Sykes PD, Neoptolemos JP, Costello E, Halloran CM. Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer. Exp Rev Gastroenterol Hepatol 2012;6: 343-56
21. Zou P, Yu Y, Wang YA, et al. Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release. Mol Pharm 2010;7:1974-84
22. Voliani V, Luin S, Ricci F, Beltram F. Single-step bifunctional coating for selectively conjugable nanoparticles. Nanoscale 2010;2: 2783-9
23. Voliani V, Ricci F, Signore G, et al. Multiphoton molecular photorelease in click-chemistry-functionalized gold nanoparticles. Small 2011;7:3271-5
24. Voliani V, Ricci F, Luin S, Beltram F. Peptidic coating for gold nanospheres multifunctionalizable with photostable and photolabile moieties. J Mat Chem 2012;22:14487-93
25. Takimoto CH, Calvo E. Principles of oncologic pharmacotherapy. In: Pazdur R, Wagman, LD, Camphausen KA, Hoskins WJ, eds. Cancer management: a multidisciplinary approach 11th ed. New York: CMP Medica
26. Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751-60
27. Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7:771-82
28. Freeman MW, Arrott A, Watson JHL. Magnetism in medicine. J Appl Phys 1960;31:S404-5
29. Wahajuddin AS,. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomed 2012;7: 3445-71
30. Cheng R, Meng F, Deng C, et al. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 2013;34:3647-57
31. Kamaly N, Xiao Z, Valencia PM, et al. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 2012;41:2971-3010
32. Medeiros SF, Santos AM, Fessi H, Elaissari A. Stimuli-responsive magnetic particles for biomedical applications. Int J Pharm 2011; 403:139-61
33. Vetter A, Reinisch A, Strunk D, et al. Thiolated polyacrylic acidmodified iron oxide nanoparticles for in vitro labeling and MRI of stem cells. J Drug Target 2011;19:562-72
34. Cai L, Niu G, Hu Z, et al. Polybutylcyanoacrylate magnetic nanoparticles as carriers of Adriamycin. J Drug Target 2009;17: 200-6
35. Veiseh O, Gunn JW, Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 2010;62:284-304
36. Jain TK, Morales MA, Sahoo SK, et al. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm 2005;2: 194-205
37. Xia Y. Nanomaterials at work in biomedical research. Nat Mat 2008;7:758-60
38. Wang H, Helliwell K, You X. Isocratic elution system for the determination of catechins, caffeine and gallic acid in green tea using HPLC. Food Chem 2000;68:115-21
39. Voliani V, Signore G, Vittorio O, et al. Cancer phototherapy in living cells by multiphoton release of doxorubicin from gold nanospheres. J Mat Chem B 2013;1:4225-30
40. Miller DL, Li P, Dou C, et al. Evans blue staining of cardiomyocytes induced by myocardial contrast echocardiography in rats: evidence for necrosis instead of apoptosis. Ultrasound Med Biol 2007;33:1988-96
41. Cengelli F, Maysinger D, Tschudi-Monnet F, et al. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures. J Pharmacol Exp Ther 2006;318:108-16
42. Hsieh W-J, Liang C-J, Chieh J-J, et al. In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibodyconjugated dextran-coated iron oxide nanoparticles. Int J Nanomed 2012;7:2833-42
43. Cirillo G, Puoci F, Iemma F, et al. Starch-quercetin conjugate by radical grafting: synthesis and biological characterization. Pharm Develop Technol 2012;17:466-76
44. Guo M, Que CL, Wang CH, et al. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery. Biomaterials 2011;32: 185-94
45. Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 2003; 36:R167-81
46. Hafeli UO, Lobedann MA, Steingroewer J, et al. Optical method for measurement of magnetophoretic mobility of individual magnetic microspheres in defined magnetic field. J Magnet Magnetic Mat 2005;293:224-39
47. Hong RY, Feng B, Chen LL, et al. Synthesis, characterization and MRI application of dextran-coated Fe3O4 magnetic nanoparticles. Biochem Eng J 2008;42:290-300
48. Voliani V, González-Béjar M, Herranz-Pérez V, et al. Orthogonal functionalisation of upconverting NaYF4 nanocrystals. Chem Eur J 2013;40:13538-46